Topic: biomedical research
In a collaboration worth up to $300 million or more, Boehringer Ingelheim tapped Epizyme to help research two regulators of genes linked to cancer.
AbbVie has signed on to be the first tenant at a new biotech campus in South San Francisco.
Perhaps nothing is more divisive in Britain today than Brexit. But what does it mean for R&D?
DNA sequencing giant Illumina has agreed to purchase smaller rival Pacific Biosciences for $1.2 billion and tighten its grasp on the market.
Four of Genentech’s former U.S. researchers are accused of passing information to a foreign rival developing biosimilars of its top drugs.
Celgene has poached a new R&D executive as it hopes to shake off past problems with a shake-up of its research unit.
Another scientist who previously worked for GSK has admitted conspiring to steal trade secrets and pass them on to a Chinese rival.
Engineers at LumaCyte and Thermo Fisher demonstrated rapid analysis of viral vaccines using a combination of optics and microfluidics.
Researchers showed AI can predict therapy responses using a radiomic biomarker, by analyzing CT images for prior immune system infiltration of tumors.
A former GSK scientist has pleaded guilty to attempting to steal confidential research and funnel it to conspirators in China.